Abstract
A clinical study using DR-70™ immunoassay for the detection of 13 different cancers have been conducted with 277 healthy subjects and 136 cancer patients. The test results showed that the DR-70™ immunoassay kit was capable of detecting cancers with high degree of specificity and sensitivity. At 95% specificity level, the sensitivity of the assay was 87.8%, 92.6%, 65.2% and 66.7%. respectively for lung, stomach, breast and rectum cancers. Furthermore the test kits were shown to be stable and performed reproducibly.
| Original language | English |
|---|---|
| Pages (from-to) | 63.0-72.0 |
| Number of pages | 10 |
| Journal | JOURNAL OF IMMUNOASSAY |
| Volume | 19 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1998 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Indexed by
- Scopus
Fingerprint
Dive into the research topics of 'Clinical performance of the AMDL DR-70™ immunoassay kit for cancer detection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver